London, UK, Boston, MA, 29 June 2026 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, today announces the appointment of Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations, effective immediately.